Format

Send to

Choose Destination
BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919.

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Author information

1
School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK jonathan.sterne@bristol.ac.uk.
2
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; and Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; and Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Boston, Massachusetts, USA.
3
School of Clinical Sciences, University of Bristol, Bristol, BS2 8HW, UK.
4
School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West) at University Hospitals Bristol NHS Foundation Trust, Bristol BS1 2NT, UK.
5
Program on Health Care Quality and Outcomes, Division of Health Services and Social Policy Research, RTI International, Research Triangle Park, NC 27709, USA.
6
RTI-UNC Evidence-based Practice Center, RTI International, Research Triangle Park, NC 27709, USA.
7
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
8
Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford OX3 7LD, UK.
9
School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada.
10
METHODS Team, Centre of Epidemiology and Statistics Sorbonne Paris Cité Research, INSERM UMR 1153, University Paris Descartes, Paris, France.
11
Department of Medical Statistics, London School of Hygiene and Tropical Medicine and MRC Clinical Trials Unit at UCL, London, UK.
12
Women's College Research Institute, Department of Medicine, University of Toronto, Canada.
13
Centre for Reviews and Dissemination, University of York, York, YO10 5DD, UK.
14
Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
15
Center for Evidence-Based Medicine, University of Southern Denmark & Odense University Hospital, 5000 Odense C, Denmark.
16
Department of Biostatistics, University of Liverpool, Liverpool, L69 3GL, UK.
17
Applied Health Research Centre (AHRC), Li Ka Shing Knowledge Institute of St Michael's Hospital, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
18
Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.
19
School of Education, Loyola University Chicago, Chicago, IL 60611, USA.
20
Health Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
21
Evidence Services, Kaiser Permanente, Care Management Institute, Oakland, CA 94612, USA.
22
Department of Management, Zicklin School of Business, Baruch College-CUNY, New York, NY 10010, USA.
23
Division of General Surgery, University of Toronto, Toronto, Canada.
24
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, L8S 4K1, Canada.
25
Departments of Clinical Epidemiology and Biostatistics and of Medicine, Cochrane Applicability and Recommendations Methods (GRADEing) Group, MacGRADE center, Ontario, L8N 4K1, Canada.
26
Ottawa Hospital Research Institute, Center for Practice Changing Research and School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada.
27
Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
28
Department of Medicine and School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada.
29
Ottawa Hospital Research Institute, Ottawa, ON, Canada.
30
University of Louisville, Louisville, KY 40292, USA.
31
International Initiative for Impact Evaluation, London School of Hygiene and Tropical Medicine, and London International Development Centre, London, UK.
32
Jack Brockhoff Child Health & Wellbeing Program, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC 3010, Australia.
33
School of Epidemiology, Public Health and Preventive Medicine and Director, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada.
34
School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK; and National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West) at University Hospitals Bristol NHS Foundation Trust, Bristol BS1 2NT, UK.
35
School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK.
PMID:
27733354
PMCID:
PMC5062054
DOI:
10.1136/bmj.i4919
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: grants from Cochrane, MRC, and NIHR during the conduct of the study. Dr Carpenter reports personal fees from Pfizer, grants and non-financial support from GSK and grants from Novartis, outside the submitted work. Dr Reeves is a co-convenor of the Cochrane Non-Randomised Studies Methods Group. The authors report no other relationships or activities that could appear to have influenced the submitted work.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center